Morning Sickness Pill Back on the Market

Now here’s some news Kate Middleton could’ve used months ago! Bendectin, a drug specifically designed to combat morning sickness, is returning after a 30-year absence. The pill had been pulled off the market after there were concerns about it causing birth defects, but a new FDA study found that the drug is “a safe and effective treatment.” “We know safety-wise, there’s zero question,” Dr. Gary Hankins of the University of Texas Medical Branch in Galveston told the Associated Press. Now called Diclegis, the drug combines Vitamin B6 and the over-the-counter antihistamine doxylamine with a delayed-release coating “designed to help women take a daily dose before their nausea sets in,” according to the AP. Diclegis is expected to hit store shelves in June.